TuHURA Biosciences (HURA) Selling, General & Administrative (2011 - 2026)
TuHURA Biosciences' Selling, General & Administrative was $2.14 million in Q2 2026, up 15.1% from $1.86 million a year earlier but down 6.7% from the prior quarter.
Powered by 
Analysis
TuHURA Biosciences (HURA) Selling, General & Administrative (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, TuHURA Biosciences' Selling, General & Administrative was $4.64 million through Jun 30, 2026, down 36.2% year-over-year; for FY2025, it was $7.58 million, up 95.8% from FY2024.
- Selling, General & Administrative shows a five-year compound annual growth rate of 10.9% (FY2020 to FY2025).
- In earlier years, Selling, General & Administrative was $3.87 million in FY2024 (-6.5%), $4.14 million in FY2023, $7.51 million in FY2022 (-23.0%) and $9.76 million in FY2021 (+116.1%).
- Quarterly Selling, General & Administrative has moved between -$1.56 million (Q4 2025) and $3.5 million (Q1 2024) over five years.
- Per Business Quant data, HURA's Selling, General & Administrative in the three quarters before Q2 2026 was $2.3 million (Q1 2026), -$1.56 million (Q4 2025) and $1.76 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | TuHURA Biosciences | 35.65 Mn | 35.65 Mn | - | 2.14 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.14 Mn |
| Mar 31, 2026 | 2.30 Mn |
| Dec 31, 2025 | -1.56 Mn |
| Sep 30, 2025 | 1.76 Mn |
| Jun 30, 2025 | 1.86 Mn |
| Mar 31, 2025 | 2.02 Mn |
| Sep 30, 2024 | 783,459.00 |
| Jun 30, 2024 | 795,660.00 |
| Mar 31, 2024 | 1.02 Mn |
| Dec 31, 2023 | 908,000.00 |
| Sep 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.30 Mn |
| Dec 31, 2022 | 1.44 Mn |
| Sep 30, 2022 | 1.48 Mn |
| Jun 30, 2022 | 1.45 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 1.99 Mn |
| Sep 30, 2021 | 2.18 Mn |
| Jun 30, 2021 | 2.67 Mn |
| Mar 31, 2021 | 2.76 Mn |
API Access
TuHURA Biosciences Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HURA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "HURA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=HURA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();